Additionally, vitamin D supplementation restored the Smad3 expression in cirrhosis and HCC patients and reduced β-catenin expression in liver tissue of HCC patients, providing a rationale for vitamin D treatment in specific patients with disrupted TGF-β signaling (32). Here, SMAD3 is linked to hepatocellular carcinoma.